Pharmacy Software Solutions | FDS

  • Home
  • Solutions
    • Pharmacy Business Intelligence & Analytics
    • Med Sync & Patient Management
    • Pharmacy Claims Reconciliation
    • DME & Medical Billing
  • Our Company
    • About FDS
    • Leadership Team
    • Partners
    • News
    • Industry Events
    • Careers
  • Resources
    • Knowledge Base
    • Resource Center
    • Case Studies
    • Webinars
      • Upcoming Webinars
      • On-Demand Webinars
    • COVID-19 Resource Center
  • Clients
    • MYDATAMART Login
    • ECONCILE Login
    • MEDBILL Login
    • EZDME Login
    • Support
    • COVID-19 Vaccine Billing FAQ

Let Us Prescribe: Pharmacists Should Be Allowed to Prescribe COVID Therapeutics

by Ryan Haddock / Thursday, 03 March 2022 / Published in Blog
President Biden delivers the State of the Union address. 2022.

On Tuesday, March 1, 2022, President Biden delivered his State of the Union address. During his speech, he laid out plans to launch a pharmacy-centered “Test to Treat” initiative. As the nation prepares to enter a new phase of the now two-year-long COVID-19 pandemic, this message couldn’t come at a more critical time.

Convenient access to community pharmacy-driven testing and treatment is necessary to combat the ongoing battle with COVID-19. And since 9 out of 10 people in the US live within five miles of a pharmacy, many will be able to get the care they desperately need because of the Administration’s new plan — even those in rural and traditionally medically underserved areas.

But there’s a problem with Biden’s announcement.

The FDA recently prohibited pharmacists from being able to administer the life-saving antiviral medications that represent the “treat” portion of the President’s historic “Test to Treat” program. Because of this action, medications like Paxlovid and Molnupiravir can only be prescribed by physicians, nurse practitioners, and physician assistants.

The FDA’s explicit blocking of community pharmacists from administering these critical anti-viral medications was a 180-degree turnaround from the Department of Health and Human Services’ announcement just last September that authorized pharmacies to “order and administer” select COVID-19 therapeutics. Despite President Biden’s goal to improve access by activating this critical pathway to care, community pharmacy is effectively banished from the Test to Treat plan.

Urgent action needs to be taken to amend the EUA and/or provide overriding authority to pharmacists so they can help the nation heal from the lingering devastation brought on by COVID-19. The government should be making access to COVID-19 treatment easier, not harder.

Here’s what you can do:

Sign the Petition
A petition was started on advocacy platform Change.org asking the FDA to let pharmacists prescribe COVID-19 treatment medications. Sign the petition and let your voice be heard! And if you’re active on social media, do your part to make #letusprescribe a trending topic.

Contact Your Elected Officials
The best way to affect government is through your elected officials. Call, email, write a letter — do whatever you have to do to ensure that your local officials know that pharmacists should be allowed to prescribe COVID-19 therapeutics. You’re mad. They should be, too.


Community pharmacists like you have been a vital part of the fight against the COVID-19 pandemic — a fight we are so close to winning. This isn’t the time to be limiting the weapons we use in that fight. Let’s tell this administration that, as pharmacists, it’s time to #LetUsPrescribe.

 

 

 

  • Tweet
Tagged under: covid-19, covid-19 treatment, department of health and human services, state of the union, test and treat, test to treat

What you can read next

How Software Can Streamline Medical Billing Training
How Software Can Streamline Medical Billing Training
empty street - community-centered care
How Pharmacies Can Fight Pandemics with Community-Centered Care
care plan implementation - fds amplicare
How to Implement a Pharmacist Care Plan Program

ABOUT US

We strengthen the health of pharmacies and their patients. At FDS, we help our clients build the clinically focused New Era Pharmacy, enabling their business to thrive now and successfully transition to a provider of community and population health with data, technology, and clinical services.

We’re not just a technology company but a team of pharmacy experts with experience and playbooks developed from our work with more than 10,000 pharmacies and partnerships with leading PSAOs. Our clients have improved adherence and care coordination in their communities while achieving significant increases to revenue and profitability.

FIND US

  • 4220 North Freeway, Fort Worth, TX 76137
  • 877.602.4179 (toll free)
  • Email Sales
  • Email Support

HOME

  • About Us
  • Contact Us
  • Careers
  • News
  • Industry Events

© 2022 EnlivenHealth. All rights reserved. | SiteMap | Privacy Policy | Terms and Conditions

TOP